Publications by authors named "Laura Albini"

Claim this Profile
N
Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study.
Nicola Squillace, Elena Delfina Ricci, Giancarlo Orofino, Gabriele Forcina, Laura Albini

BMC Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, safety, and patient-reported outcomes of bictegravir/emtricitabine/tenofovir alafenamide in routine clinical care in Italy: 12-Month results from the BICSTaR cohort.
Andrea Antinori, Giulia Marchetti, Vincenzo Esposito, Stefano Rusconi, Diana Canetti, Laura Albini

Int J STD AIDS· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study.
Elena Raffetti, Laura Albini, Daria Gotti, Daniela Segala, Franco Maggiolo

BMC Public Health· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study.
Daria Gotti, Elena Raffetti, Laura Albini, Laura Sighinolfi, Franco Maggiolo

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.
Laura Albini, Alessandra Calabresi, Daria Gotti, Alice Ferraresi, Andrea Festa

AIDS Res Hum Retroviruses· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
Margalida Rotger, Tracy R Glass, Thomas Junier, Jens Lundgren, James D Neaton, Laura Albini

Clin Infect Dis· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy.
Daria Gotti, Marta Danesi, Alessandra Calabresi, Alice Ferraresi, Laura Albini

AIDS Patient Care STDS· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increase in standard cholesterol and large HDL particle subclasses in antiretroviral-naïve patients prescribed efavirenz compared to atazanavir/ritonavir.
Daria Gotti, Bruno Mario Cesana, Laura Albini, Alessandra Calabresi, Ilaria Izzo

HIV Clin Trials· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The disagreement among methods to evaluate glomerular filtration rate in HIV-infected patients naive to antiretroviral therapy.
Laura Albini, Emanuele Focà, Davide Motta, Daria Gotti, Giuseppe Lapadula

AIDS Res Hum Retroviruses· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of detectable human cytomegalovirus DNAemia on viro-immunological effectiveness of HAART in HIV-infected patients naive to antiretroviral therapy.
Emanuele Focà, Davide Motta, Caterina Pollara, Nigritella Brianese, Daria Gotti, Laura Albini

New Microbiol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.
Emanuele Focà, Davide Motta, Marco Borderi, Daria Gotti, Laura Albini

BMC Infect Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz.
Laura Albini, Bruno Mario Cesana, Davide Motta, Emanuele Focà, Daria Gotti

J Acquir Immune Defic Syndr· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
Monia Mendeni, Emanuele Focà, Daria Gotti, Nicoletta Ladisa, Gioacchino Angarano, Laura Albini

Clin Infect Dis· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules.
Daria Gotti, Emanuele Focà, Laura Albini, Monia Mendeni, Andrea Vavassori

Curr HIV Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis